Author:
Wuillème S,Lok A,Robillard N,Dupuis P,Stocco V,Migné H,Dusquesne A,Touzeau C,Tiab M,Béné M C,Moreau P
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference12 articles.
1. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi F et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med 1996; 335: 91–97.
2. Fermand JP, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F et al. High-dose chemotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005–2009.
3. Henry JM, Sykes PJ, Brisco MJ, To LB, Juttner CA, Morley AA . Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. Br J Haematol 1996; 92: 614–619.
4. Mariette X, Fermand JP, Brouet JC . Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant 1994; 14: 47–50.
5. Kopp HG, Yildirim S, Weisel KC, Kanz L, Vogel W . Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma. J Cancer Res Clin Oncol 2009; 135: 637–642.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献